NOT FOR DISTRIBUTION
Header cover image

Market Cap

UK£22.5m

Last Updated

2021/05/09 21:21 UTC

Data Sources

Company Financials +

Executive Summary

Iofina plc engages in the exploration and production of iodine, iodine specialty chemical derivatives, produced water, and natural gas in the United States and the United Kingdom. More Details


Snowflake Analysis

Very undervalued with high growth potential.

Share Price & News

How has Iofina's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IOF is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: IOF's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

2.2%

IOF

-0.05%

GB Chemicals

2.1%

GB Market


1 Year Return

-15.8%

IOF

47.9%

GB Chemicals

26.3%

GB Market

Return vs Industry: IOF underperformed the UK Chemicals industry which returned 48.9% over the past year.

Return vs Market: IOF underperformed the UK Market which returned 26.5% over the past year.


Shareholder returns

IOFIndustryMarket
7 Day2.2%-0.05%2.1%
30 Day-6.9%4.0%3.5%
90 Day-4.9%8.3%8.8%
1 Year-15.8%-15.8%50.2%47.9%31.9%26.3%
3 Year-33.4%-33.4%12.4%2.0%12.9%-0.1%
5 Year-29.3%-29.3%53.0%29.9%51.5%22.8%

Long-Term Price Volatility Vs. Market

How volatile is Iofina's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Iofina undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: IOF (£0.12) is trading below our estimate of fair value (£0.28)

Significantly Below Fair Value: IOF is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: IOF is good value based on its PE Ratio (14.5x) compared to the GB Chemicals industry average (43.4x).

PE vs Market: IOF is good value based on its PE Ratio (14.5x) compared to the UK market (26.1x).


Price to Earnings Growth Ratio

PEG Ratio: IOF is good value based on its PEG Ratio (0.2x)


Price to Book Ratio

PB vs Industry: IOF is good value based on its PB Ratio (1.5x) compared to the GB Chemicals industry average (3.5x).


Future Growth

How is Iofina forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

79.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IOF's forecast earnings growth (79.1% per year) is above the savings rate (0.9%).

Earnings vs Market: IOF's earnings (79.1% per year) are forecast to grow faster than the UK market (17.5% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: IOF's revenue (10.4% per year) is forecast to grow faster than the UK market (5.3% per year).

High Growth Revenue: IOF's revenue (10.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IOF's Return on Equity is forecast to be high in 3 years time (20.1%)


Past Performance

How has Iofina performed over the past 5 years?

29.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IOF has high quality earnings.

Growing Profit Margin: IOF became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: IOF has become profitable over the past 5 years, growing earnings by 29.3% per year.

Accelerating Growth: IOF has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: IOF has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-12.7%).


Return on Equity

High ROE: IOF's Return on Equity (10.5%) is considered low.


Financial Health

How is Iofina's financial position?


Financial Position Analysis

Short Term Liabilities: IOF's short term assets ($20.4M) do not cover its short term liabilities ($21.6M).

Long Term Liabilities: IOF's short term assets ($20.4M) exceed its long term liabilities ($1.2M).


Debt to Equity History and Analysis

Debt Level: IOF's debt to equity ratio (80%) is considered high.

Reducing Debt: IOF's debt to equity ratio has reduced from 83.4% to 80% over the past 5 years.

Debt Coverage: IOF's debt is not well covered by operating cash flow (18.4%).

Interest Coverage: IOF's interest payments on its debt are not well covered by EBIT (2.4x coverage).


Balance Sheet


Dividend

What is Iofina current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IOF's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IOF's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IOF's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IOF's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IOF's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.7yrs

Average management tenure


CEO

Tom Becker (50 yo)

6.67yrs

Tenure

US$275,600

Compensation

Dr. Thomas Matthew Becker, also known as Tom, has been the Chief Executive Officer and President of Iofina plc since September 5, 2014. Dr. Becker served as the President of Iofina Chemical Inc., at Iofina...


CEO Compensation Analysis

Compensation vs Market: Tom's total compensation ($USD275.60K) is about average for companies of similar size in the UK market ($USD338.50K).

Compensation vs Earnings: Tom's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: IOF's management team is seasoned and experienced (6.7 years average tenure).


Board Members

Experienced Board: IOF's board of directors are considered experienced (5.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: IOF insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Iofina plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Iofina plc
  • Ticker: IOF
  • Exchange: AIM
  • Founded: 2005
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: UK£22.543m
  • Shares outstanding: 191.86m
  • Website: https://www.iofina.com

Number of Employees


Location

  • Iofina plc
  • 48 Chancery Lane
  • London
  • Greater London
  • WC2A 1JF
  • United Kingdom

Listings


Biography

Iofina plc engages in the exploration and production of iodine, iodine specialty chemical derivatives, produced water, and natural gas in the United States and the United Kingdom. It offers halogen chemica...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/09 21:21
End of Day Share Price2021/05/07 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.